A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy
Clinical trial NCT07642050 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07642050
- Sponsor
- Biohaven Therapeutics Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-09-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.